This podcast discusses the proposed rule change that CMS has made to Medicare Advantage and Part D around DIR Fees. Nick Gentile and Jillanne Schulte go through why this rule change was made, how it will effect ASHP members, and what ASHP members can do.
SPEAKERS
Jillanne Schulte Wall is the senior director of Health & Regulatory Policy for the American Society of Health-System Pharmacists (ASHP) in Bethesda, MD. She serves as ASHP’s primary liaison to federal regulatory agencies and, in conjunction with other members of the Government Relations team, develops and communicates of ASHP’s positions on federal and state laws, regulations, and guidance related to the profession of pharmacy. Additionally, Jillanne works closely with stakeholders in pharmacy, medicine, manufacturing, and patient advocacy on legislative and regulatory issues of importance to ASHP members.
Nick Gentile is the director of Political Action Committee and Grassroots Engagement for the American Society of Health-System Pharmacists. In this position, he promotes ASHP’s grassroots mobilization efforts and its political action committee, ASHP-PAC. He received his bachelor’s degree from The American University, where he majored in political science and law in society. Prior to ASHP, Nick spent ten years at the National Association of Home Builders (NAHB) working in various positions within the government affairs department. He worked with state and local government affairs issues, federal relations, grassroots mobilization and BUILD-PAC (NAHB’s political action committee).